A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months

NCT01699464 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Open-angle Glaucoma

Interventions

DRUG: AR-12286 Ophthalmic Solution 0.7%
DRUG: AR-12286 Ophthalmic Solution 0.5%
DRUG: Timolol maleate ophthalmic solution 0.5%

Sponsor

Aerie Pharmaceuticals